1. BASDEVANT A, LAVILLE M, ZIEGLER O
et al. Recommandation pour le diagnostic, la prévention
et le traitement des obésités en France.
Cah. Nut. Diet., 1998, 33, sup 1, 1-48
2. DESPRES JP. Dyslipidemia and obesity. J. Clin. Endocrinol.
Metab. 1994, 8, 629-60
3. WHO (World Health Organization). Obesity : preventing
& managing the global epidermic. Report of a WHO Consultation
on Obesity. Geneva, 3-5 June, 1997
4. BRAY GA, Complication of Obesity. Ann Int Med. 1995
: 103 (Spt 2) : 1052-1062
5. LAPIDUS L, BENGTSSON C, LARSSON B et al. Distribution
of adipose tissue and risk of cardiovascular desease and
death : a 12 year follow-up of participants in the population
study of women in Göteborg, Sweden. Br Med J 1984,
289, 1257-61
6.BJÖRNTORP P. Obesity. Lancet 1997, 350 : 453-26
7. DESPRES JP. Obésité dans le DNID : Pertinence
du contrôle de la masse grasse ou de sa répartition.
Journée de Diabétologie de l'Hôtel-Dieu
1998. Flammarion Médecine Sciences, pp.215-21
8. BJÖRNTORP Per. Visceral Obesity : A "Civilization
Syndrome". Obesity Research. May 1993, 1, 206-222
9. ROLLAND-CACHERA MF, COLE TJ, SEMPE M, TICKET J, ROSSIGNOL
C, CHARRAUD A. Variation of the Wt / Ht2 index from birth
to age 87 years. Eur J Clin Nutr, 1991, 45, 13-21
10. ObEpi. "L'Obésité en France"
(Vol. 1). Prévalence de l'obésité
estimée en fonction de l'IMC dans un échantillon
représentatif de la population française.
Enquête SOFRES et INSERM 1998
11. MAILLARD G, CHARLES MA, THIBULT N, FORHAN A, SERMET
C, BASDEVANT A et al. Trends in the prevalence of obesity
in the French adult population between 1980 and 1991.
Int. J. Obesity 1999, 23 : 389-394
12. WHITAKER RC, WRIGHT JA, PEPE MS. Predicting obesity
in youth adulthood from childhood obesity. N. Engl. J.
Med 1997, 337 : 869
13. BRAY GA. Classification and evaluation of the obesities.
Med Clin North Am 1989; 5 : 83-103
14. LEMIEUX S, PRUD'HOMME D, BOUCHARD C, TREMBLAY A, DESPRES
JP. Sex differences in the rrelation of visceral adipose
tissue accumulation to total body fatness. Am J. Clin
Nutr 1993, 58, 463-7
15. ROLLAND-CACHERA MF, DEHEEGER M, BELLISLE F et al.
Influence of body fat distribution during childhood on
body fat distribution in adulthood. Int J Obes 1990; 14
: 473-81
16. ROLLAND-CACHERA MF et al. Variation of the body mass
index in the French population from 0 to 87 years. In
obesity in Europe. 1991, Ed Ailhaud et al. John Libbery
& Compagny. 113-120
17. CAMPFIELD et al. Protéine ob et son récepteur.
Journée de Diabétologie de l'Hôtel
Dieu 1997. Flammarion Médecine Sciences
18. BLUNDELL JE. Research methodologies for the study
of human feeding behavior. In Meyer p, Chaouloff F, Gilbert
JC, Rolland Y. Médicaments et comportement alimentaire.
Paris, Masson 1993
19. LE BARZIC M, BASDEVANT A, GUY-GRAND B. Troubles du
comportmement alimentaire chez l'adulte. Editions techniques.
EMC. 1992, 25201-A10
20. BOUCHARD. Génétique et obésité
chez l'homme. Diabetes & Metabolism, 1988, 14, 407-413
|
|
21. RAVUSIN et al. Reduced
rate of energy expenditure as a risk factor for weight
gain. New Eng. J. Med 1988; 318, 476.72
22. BOUCHARD C, PERUSSE F, LEBLAN C, TREMBLAY A, THERIAULT
G. Inheritance of the amount and distribution of human
body fat. Int J Obes 1988, 12, 205-15
23. PRENTICE A, JEBBS S. Obesity in Britain : gluthony
or sloth ?. BMJ, 1995, 31, 457-9
24.Obésités : qualité de vie et coût
socio-économique. Ardix Medical 1996
25. FERRE Pascal. Physiopathologie des adipocytes. In
La masse grasse. Ed. B. Messing et MS Billaux 1998. Arnette
26. RAVUSSIN E, SWINBURN BA. Energy metabolism. In : Stunkard
AJ; Wadden TA'eds. Obesity : theory and therapy. New York
: Raven Press 1993 : 97-123
27. LEIBEL RL, ROSENBAUM M, HIRSCH J. Chenges in energy
expenditure resulting from altered body weight. N. Engl.
J. Med 1997. Vol 332, 621-628
28. BASDEVANT A. Clinique des obésités.
Médecine Sciences 1998; 14, 925-934
29. LEW EA, GARFINKEL L. Variation in mortality by weight
among 750 000 men and women. J. Chron. Dis. 1979; 32,
13 : 563-576
30. UKPDS. Les effets de la metformine utilisée
comme traitement intensif de contrôle de la glycémie
sur les c omplications observées chez les patients
en surpoids diabétiques de type 2 (UKPDS 34). Lancet
1998, 352, 9131, 854-865
31. Tables de composition des aliments. Ed. Jacques Lanore
1996
32. PAN A. EU Survey on Consumer Attitudes to Physical
Activity, Body-weight and Health. Employment and Social
Affairs. Commission Européenne 1999
33. Risques somatiques des obésités. Ardix
Medical 1998
34. BSDEVANT A, CRAPLET C, GUY-GRAND B. Snacking patterns
in a french obese female population. Appetite 1993; 21,
17-23
35.GUERCIOLINI R. Mode of action of Orlistat. Int. J.
Obes. 1997; 21 (suppl 3) : 512-523
36. SJOSTRÖM L, RISSANEN A, ANDERSEN T, BOLDRIN M,
GOLAY A, KOPPESCHAAR HPF, KREMPF M. Randomised placebo-controlled
trial of orlistat for weight loss and prevention of weight
regain in obese patients. Lancet 1998; 352 : 167-172
37. GUY-GRAND B. Randomised placebo-controlled trial of
obesity in human obesity. Annals of New-York Academy of
Sciences 1987; vol. 499, 313-317
38. KRAL J.G. Surgical treratment of obesity. In : Obesity;
P. Björntorp, B.N. Brodoll. J.B. Lipincott Company
1992
39. MAC NEILL G. Energy in human nutrition and dietetics.
Ed. by J.S. GARROW, W.P.T. JAMES - Churchill Livingstone
Edimbourgh 1982
40. RISSANEN A, HELIOVAARA M, KNEKT P, REUNANEN A, ARONAA
A, MAATELA J. Risk of disability and mortality due to
overweight in a finnish population. BMJ 1990; 301, 835-837
41. GORTMAKER SL, MUST A, PERRIN JM, SOBOL AM, DIETZ WH.
Social and economic consequences of overweight in adolescence
and young adulthood. N. Engl. J. Med. 1993; 329, 1008-1012
|
